NGO accuses tobacco industry and Switzerland of human rights violations
Smoking causes around 9,500 deaths in Switzerland every year and 8 million worldwide.
Keystone / Anthony Anex
Select your language
Generated with artificial intelligence.
Listening: NGO accuses tobacco industry and Switzerland of human rights violations
In a report published on Tuesday, the anti-smoking association OxySuisse has accused multinationals in the tobacco industry of violating human rights and the Swiss authorities of being complacent towards them.
This content was published on
2 minutes
RTS
Português
pt
ONG acusa indústria do tabaco e Suíça de violações de direitos humanos
Produced in collaboration with the US organisation Action on Smoking and Health, the OxySuisse reportExternal link analyses the tobacco industry’s influence from a human rights perspective.
According to the report, the tobacco industry is incompatible with fundamental human rights. The production and marketing of addictive and deadly products violates the right to health, the right to life and the right to a healthy environment, OxySuisse says.
Smoking causes around 9,500 deaths in Switzerland every year and 8 million worldwide.
More
More
Why Switzerland has one of the world’s strongest tobacco lobbies
This content was published on
With Sunday’s vote, Switzerland is bringing its tobacco control regime in line with Europe. Why did it take so long?
The association points out that Switzerland is lagging far behind in the fight against smoking, coming 36th out of 37 European countries.
According to OxySuisse, this delay can be explained by the weight of the tobacco industry in the Swiss Confederation. “The presence in Switzerland of two of the country’s influential tobacco multinationals is one of the reasons for the failure to implement effective smoking prevention policies,” Michela Canevascini, Director of OxySuisse, told Swiss public television RTS on Tuesday.
“We (Switzerland, editor’s note) often give priority to the commercial interests of these companies to the detriment of the Swiss population’s right to health.”
External Content
Translated from French by DeepL/jdp
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.